My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 241

    1.

    Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

    Temple R, Ellenberg SS.

    Ann Intern Med. 2000 Sep 19;133(6):455-63.PMID: 10975964 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

    Ellenberg SS, Temple R.

    Ann Intern Med. 2000 Sep 19;133(6):464-70.PMID: 10975965 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Placebo-controlled studies in depression: necessary, ethical and feasible.

    Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller HJ.

    Eur Arch Psychiatry Clin Neurosci. 2003 Feb;253(1):22-8. Review.PMID: 12664309 [PubMed - indexed for MEDLINE]Related articles

    4.

    Placebo or active control trials of antipsychotic drugs?

    Fleischhacker WW, Czobor P, Hummer M, Kemmler G, Kohnen R, Volavka J.

    Arch Gen Psychiatry. 2003 May;60(5):458-64. Review.PMID: 12742866 [PubMed - indexed for MEDLINE]Related articles

    5.

    Are placebo-controlled clinical trials ethical or needed when alternative treatment exists?

    Simon R.

    Ann Intern Med. 2000 Sep 19;133(6):474-5. No abstract available. Erratum in: Ann Intern Med 2000 Nov 7;133(9):754. PMID: 10975967 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    What makes placebo-controlled trials unethical?

    Miller FG, Brody H.

    Am J Bioeth. 2002 Spring;2(2):3-9.PMID: 12189059 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control]

    Broich K.

    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 May;48(5):541-7. Review. German. PMID: 15887064 [PubMed - indexed for MEDLINE]Related articles

    8.

    The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia.

    Carpenter WT Jr, Appelbaum PS, Levine RJ.

    Am J Psychiatry. 2003 Feb;160(2):356-62.PMID: 12562584 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The ethical use of placebo controls in clinical research: the Declaration of Helsinki.

    La Vaque TJ, Rossiter T.

    Appl Psychophysiol Biofeedback. 2001 Mar;26(1):23-37; discussion 61-5.PMID: 11387859 [PubMed - indexed for MEDLINE]Related articles

    10.

    Placebo and the Helsinki Declaration--what to do?

    Vrhovac B.

    Sci Eng Ethics. 2004 Jan;10(1):81-93. Review.PMID: 14986775 [PubMed - indexed for MEDLINE]Related articles

    11.

    Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?

    Brody BA, Dickey N, Ellenberg SS, Heaney RP, Levine RJ, O'Brien RL, Purtilo RB, Weijer C.

    J Bone Miner Res. 2003 Jun;18(6):1105-9.PMID: 12817764 [PubMed - indexed for MEDLINE]Related articles

    12.

    Placebo-controlled trials in psychiatric research: an ethical perspective.

    Miller FG.

    Biol Psychiatry. 2000 Apr 15;47(8):707-16.PMID: 10773177 [PubMed - indexed for MEDLINE]Related articles

    13.

    Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.

    D'Agostino RB Sr, Massaro JM, Sullivan LM.

    Stat Med. 2003 Jan 30;22(2):169-86.PMID: 12520555 [PubMed - indexed for MEDLINE]Related articles

    14.

    Placebo-controlled trials and the Declaration of Helsinki.

    Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B.

    Lancet. 2002 Apr 13;359(9314):1337-40.PMID: 11965296 [PubMed - indexed for MEDLINE]Related articles

    15.

    The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis.

    Delmas PD, Calvo G, Boers M, Abadie E, Avouac B, Kahan A, Kaufman JM, Laslop A, Lekkerkerker JF, Nilsson P, Van Zwieten-Boot B, Kreutz G, Reginster JY; Group for the Respect of Ethics and Excellence in Science (GREES).

    Osteoporos Int. 2002 Jan;13(1):1-5. Review.PMID: 11878450 [PubMed - indexed for MEDLINE]Related articles

    16.

    Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.

    Rosenblatt M.

    J Bone Miner Res. 2003 Jun;18(6):1142-5.PMID: 12817772 [PubMed - indexed for MEDLINE]Related articles

    17.

    When are placebo-controlled trials no longer appropriate?

    Brody BA.

    Control Clin Trials. 1997 Dec;18(6):602-12; discussion 661-6.PMID: 9408722 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical trials: active control vs placebo--what is ethical?

    Spławiński J, Kuźniar J.

    Sci Eng Ethics. 2004 Jan;10(1):73-9. Review.PMID: 14986774 [PubMed - indexed for MEDLINE]Related articles

    19.

    Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?

    Weijer C.

    Schizophr Res. 1999 Feb 15;35(3):211-8; discussion 227-36.PMID: 10093865 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Ethical implications of placebo-controlled clinical trials for psychotropic drugs]

    Helmchen H.

    Nervenarzt. 2005 Nov;76(11):1319-29. Review. German. Erratum in: Nervenarzt. 2006 Mar;77(3):354. PMID: 15812676 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity